Peripheral neuropathy — all decisions

The Board remands the veteran's claims for a higher rating and compensation under 38 U.S.C. § 1151 due to concerns regarding the qualifications of the VA examiner.

The Board remands the claims for service connection due to insufficient evidence and the need for additional medical opinions.

The Board denied service connection for an acquired psychiatric disorder, bilateral peripheral neuropathy of the lower extremities, and skeletal arthritis as there was no evidence to support a finding that these conditions were incurred in or aggravated by active military service.

The Veteran is granted special monthly compensation at the intermediate rate between (m) and (n), effective October 24, 2023. The Board remands issues related to higher staged ratings for diabetic peripheral neuropathy in both upper extremities and higher levels of special monthly compensation.

The Board denied service connection for cervical strain and a compensable rating for scars post-removal of squamous cell carcinomas, while remanding several other claims including diabetes mellitus, type II, diabetic neuropathies, obstructive sleep apnea, hypertension, left knee disability, traumatic brain injury with post-concussion syndrome migraines, and left hip disability.

The Board dismissed the veteran's appeal for an earlier effective date for service connection for right and left upper and lower extremity CIDP due to a prohibited concurrent election under the Appeals Modernization Act.

The Board dismissed the Veteran's appeals for service connection for various conditions due to untimely filing of the December 2024 VA Form 10182.

The Board remands the claims for further development, including obtaining relevant VA treatment records and a supplemental medical opinion to address the severity of the Veteran's peripheral neuropathy without considering medication effects.

The Board granted an earlier effective date of June 6, 2019, for the evaluation and service connection of peripheral neuropathy in both upper extremities.

The appeal is dismissed due to the death of the Veteran.

The Board remands the claims for a VA neurological examination to determine the nature and severity of the service-connected right lower extremity and left lower extremity diabetic peripheral neuropathy.

The Board remands the claims for service connection for peripheral neuropathy of both lower extremities to obtain a VA medical opinion regarding whether the current condition is caused or aggravated by the Veteran's service-connected diabetes mellitus type II.

The Board dismissed the appeals for service connection and increased ratings as they were duplicate appeals that had been addressed in a separate appeal.

The Board denied service connection for the cause of death, finding that the Veteran's service-connected ischemic optic neuropathy of the left eye did not cause or contribute substantially to his death.

The Board granted earlier effective dates for the awards of service connection for various conditions associated with a stroke, including obstructive sleep apnea, depression, and diabetes mellitus type II.

The Board remands the claims for service connection and increased ratings due to a procedural error regarding notice of the right to a pre-decisional hearing.

The Board denied service connection for segmental colitis associated with diverticulosis, small bowel obstruction, to include small bowel perforation, status post left hemicolectomy, Hartman's pouch and ileostomy (bowel condition), as well as right and left upper and lower extremity peripheral neuropathy.

The Board remands the claim for a bilateral foot disability to obtain further development, including adequate VA examinations and opinions.

The Veteran is granted special monthly compensation (SMC) based on the need for regular aid and attendance due to his service-connected disabilities.

The Board granted a 20 percent disability rating for diabetic peripheral neuropathy of the right and left lower extremities (both femoral and sciatic nerves) but remanded claims for an increased rating for transient ischemic attack and entitlement to TDIU.